Obesity in France
France, officially known as the French Republic, is a country located in Europe. It is known for its rich history, culture, and contributions to art, science, and philosophy. France is also recognized for its healthcare system, which is considered one of the best in the world.
In 2016, France had an adult obesity rate of 21.6%, ranking it 87th globally. This means that over a fifth of the adult population in France was classified as obese, according to the Body Mass Index (BMI) scale. Obesity is a significant health issue that can lead to various complications, including heart disease, diabetes, and certain types of cancer.
Despite the relatively high obesity rate, France has a number of well-known healthcare facilities dedicated to weight loss and obesity management. These include:
- Pitié-Salpêtrière Hospital in Paris, which has a specialized department for endocrinology, metabolism, and nutrition.
- Léon Bérard Center in Lyon, a leading center for cancer treatment, including obesity-related cancers.
- Thalazur Cabourg Thalassotherapy & Spa, a wellness center that offers weight loss programs and treatments.
The French government and healthcare system have implemented various measures to combat obesity. These include public health campaigns promoting healthy eating and physical activity, regulations on food advertising, and the provision of weight management services through the healthcare system.
Despite these efforts, obesity remains a significant challenge in France, reflecting broader global trends. Continued research, policy development, and public health interventions are needed to address this issue.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian